These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 10873778
1. Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus. Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF. Virology; 2000 Jul 05; 272(2):347-56. PubMed ID: 10873778 [Abstract] [Full Text] [Related]
2. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. Su J, Luscher MA, Xiong Y, Rustam T, Amara RR, Rakasz E, Robinson HL, MacDonald KS. Int Immunol; 2005 May 05; 17(5):637-48. PubMed ID: 15824066 [Abstract] [Full Text] [Related]
3. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. Allen TM, Sidney J, del Guercio MF, Glickman RL, Lensmeyer GL, Wiebe DA, DeMars R, Pauza CD, Johnson RP, Sette A, Watkins DI. J Immunol; 1998 Jun 15; 160(12):6062-71. PubMed ID: 9637523 [Abstract] [Full Text] [Related]
4. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Nixon DF, Donahoe SM, Kakimoto WM, Samuel RV, Metzner KJ, Gettie A, Hanke T, Marx PA, Connor RI. Virology; 2000 Jan 05; 266(1):203-10. PubMed ID: 10612675 [Abstract] [Full Text] [Related]
5. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G. J Immunol; 2009 Jul 01; 183(1):706-17. PubMed ID: 19542473 [Abstract] [Full Text] [Related]
6. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease. Peut V, Kent SJ. Virology; 2009 Feb 05; 384(1):21-7. PubMed ID: 19091370 [Abstract] [Full Text] [Related]
7. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge. Mortara L, Letourneur F, Villefroy P, Beyer C, Gras-Masse H, Guillet JG, Bourgault-Villada I. Virology; 2000 Dec 20; 278(2):551-61. PubMed ID: 11118377 [Abstract] [Full Text] [Related]
8. Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques. Coutsinos Z, Villefroy P, Gras-Masse H, Guillet JG, Bourgault-Villada I. FEMS Immunol Med Microbiol; 2005 Mar 01; 43(3):357-66. PubMed ID: 15708309 [Abstract] [Full Text] [Related]
9. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques. Malkevitch N, Patterson LJ, Aldrich K, Richardson E, Alvord WG, Robert-Guroff M. J Immunol; 2003 Apr 15; 170(8):4281-9. PubMed ID: 12682263 [Abstract] [Full Text] [Related]
10. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. Murphey-Corb M, Wilson LA, Trichel AM, Roberts DE, Xu K, Ohkawa S, Woodson B, Bohm R, Blanchard J. J Immunol; 1999 Jan 01; 162(1):540-9. PubMed ID: 9886431 [Abstract] [Full Text] [Related]
11. Clonal repertoires of virus-specific CD8+ T lymphocytes are shared in mucosal and systemic compartments during chronic simian immunodeficiency virus infection in rhesus monkeys. Sircar P, Furr KL, Dorosh LA, Letvin NL. J Immunol; 2010 Aug 15; 185(4):2191-9. PubMed ID: 20624939 [Abstract] [Full Text] [Related]
12. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Voss G, Li J, Manson K, Wyand M, Sodroski J, Letvin NL. Virology; 1995 Apr 20; 208(2):770-5. PubMed ID: 7747449 [Abstract] [Full Text] [Related]
17. Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay. Vogel T, Norley S, Beer B, Kurth R. Immunology; 1995 Mar 20; 84(3):482-7. PubMed ID: 7751033 [Abstract] [Full Text] [Related]
18. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction. Letvin NL, Miller MD, Shen L, Chen ZW, Yasutomi Y. Semin Immunol; 1993 Jun 20; 5(3):215-23. PubMed ID: 8394161 [Abstract] [Full Text] [Related]
19. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses. Malkevitch NV, Patterson LJ, Aldrich MK, Wu Y, Venzon D, Florese RH, Kalyanaraman VS, Pal R, Lee EM, Zhao J, Cristillo A, Robert-Guroff M. Virology; 2006 Sep 15; 353(1):83-98. PubMed ID: 16814356 [Abstract] [Full Text] [Related]
20. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques. Nakamura M, Takahara Y, Ishii H, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T, Matsuoka S. Microbiol Immunol; 2011 Nov 15; 55(11):768-73. PubMed ID: 21895748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]